Sumoylation of the major immediate-early IE2 protein of human cytomegalovirus has been shown to increase transactivation activity in target reporter gene assays. This study examined the role of IE2 sumoylation in viral infection. A Towne strain-based bacterial artificial chromosome clone was generated encoding a mutated form of the IE2 protein with LysRArg substitutions at positions 175 and 180, the two major sumoylation sites. When human fibroblast (HF) cells were infected with the reconstituted mutant virus, (i) viral growth kinetics, (ii) the accumulation of IE1 (UL123), IE2 (UL122), p52 (UL44) and pp65 (UL83) proteins and (iii) the relocalization of the cellular small ubiquitin-like modifier (SUMO)-1, p53 and proliferating cell nuclear antigen proteins into viral DNA replication compartments were comparable with those of the wild-type and the revertant virus. The data demonstrate that sumoylation of IE2 is not essential for virus growth in cultured HF cells.
The major immediate-early IE2 (IE86 or ppUL122) protein of human cytomegalovirus (HCMV) has been shown to be a promiscuous transcriptional activator. IE2 interacts with components of the basal transcription complex and numerous transcription factors, as well as with cell cycle modulators such as the retinoblastoma protein and p53 (Castillo & Kowalik, 2002, and references therein) . A study using a recombinant viral genome revealed that IE2 is essential for the expression of all lytic cycle viral genes in tissue culture (Marchini et al., 2001) . IE2 was also found to act as a repressor of its own major IE (MIE) promoter by directly binding to the MIE cis repression signal near the 59 cap site (Liu et al., 1991; Pizzorno & Hayward, 1990; Pizzorno et al., 1988) . Studies on the intranuclear targeting of IE2 have shown that IE2 initially targets adjacent to premyelocytic leukaemia (PML) protein-associated nuclear bodies, known as PML oncogenic domains (PODs) or nuclear domain 10 (ND10), to form immediate transcription domains, and accumulates in viral DNA replication compartments at the later stages of infection (Ahn et al., 1999; Ishov et al., 1997) .
IE2 has been shown to be covalently modified by small ubiquitin-like modifiers (SUMOs) at two Lys residues at positions 175 and 180 (Ahn et al., 2001; Hofmann et al., 2000) . Several studies have suggested that sumoylation of IE2 is associated with the increased transactivation activity of IE2 in target reporter gene assays in DNAtransfected cells. Hofmann et al. (2000) reported that a sumoylation-deficient K175/180R mutant IE2 from the AD169 strain of HCMV showed significantly reduced transcriptional activation of the two viral promoters UL84 and UL112-113. In a study using IE2 from the Towne strain, it was shown that transactivation of the polymerase (UL54) promoter by the K175/180R mutant IE2 was only slightly reduced compared with the wild-type. However, IE2-mediated transactivation of the cellular cyclin E promoter was significantly increased in cells co-transfected with SUMO-1 and Ubc9, a SUMO E2 conjugation enzyme (Ahn et al., 2001) . In a previous study, we found that PIAS1, known as a SUMO E3 ligase, enhanced the sumoylation level of IE2 and thereby increased the IE2-mediated transactivation of both UL54 and cyclin E promoters (Lee et al., 2003) . Recently, a correlation between the transactivation activity of IE2 and its sumoylation level was suggested by an analysis of IE2 variations in different HCMV strains (Barrasa et al., 2003) . In this study, a ThrRAla substitution at position 541 significantly increased both the sumoylation level and the transactivation activity of IE2. This appears to be the primary reason why IE2 of the AD169 strain has a higher transactivation activity than that of the Towne strain. However, all of these functional assays were carried out in cells transiently co-transfected with DNA. Therefore, it is not clear whether the sumoylation of IE2 does in fact play a role in viral infection.
To examine whether sumoylation of IE2 is required for virus growth, we generated a recombinant HCMV genome encoding the K175/180R mutant IE2. A bacterial artificial chromosome (BAC) was used to create a Towne strain HCMV-BAC clone (T-BAC) (Marchini et al., 2001) , which was used as a template for mutagenesis (Fig. 1a) . This clone has a 9 kb deletion from a dispensable part of the US region (from US1 to US12) and contains both F plasmid sequences and a GFP expression cassette in the deleted region. To create a transfer vector for IE2 mutagenesis, a 2?4 kb BglII-StuI fragment containing the IE2(K175/ 180R) allele from the Towne strain was cloned into pGS284, a derivative of the positive suicide selection vector pCV442 (Marchini et al., 2001) . To transfer the DNA sequences in pGS284 to T-BAC, Escherichia coli S17-lpir containing the GS284 donor plasmid was conjugated with a RecA + derivative of E. coli DH10B harbouring the T-BAC DNA (Smith & Enquist, 1999) . Co-integrates and exoconjugates were selected sequentially with antibiotics and sucrose (Fig. 1b) . To isolate recombinant T-BAC clones containing mutations, DNA fragments containing the mutated allele were amplified by PCR and sequenced directly (Fig. 1c) . In addition, the lack of any apparent alteration of the viral genome was checked by comparing the restriction endonuclease digestion patterns of the wild-type and mutant T-BAC clones (data not shown). The revertant T-BAC clone was generated by the allelic exchange of the mutant with the 4?1 kb PvuII-SalI wild-type fragment cloned in pGS284. The correct conversion of the mutant allele into the wild-type allele was confirmed by direct sequencing (data not shown).
To investigate whether the T-BAC clone encoding IE2(K175/180R) was infectious, we electroporated purified T-BAC-wt or T-BAC-IE2(K175/180R) into permissive human fibroblast (HF) cells and monitored the electroporated cultures for virus growth by evaluating the spread of GFP signal and the cytopathic effect on cells. T-BACDexon5, which lacks exon 5 of IE2 and is not infectious (Marchini et al., 2001) , was used as a negative control. For each electroporation, 5610 6 HF cells suspended in 250 ml medium supplemented with 10 % serum were mixed with 4 mg BAC DNA, 1 mg plasmid pCMV71 encoding pp71 (UL82) and 1 mg plasmid pEGFP-N1 (Clontech) in a 0?4 cm Supernatants were collected at various times after infection and the titre of the infectious progeny virus was determined by plaque assays. Our results showed that the growth kinetics of the mutant virus were slightly delayed relative to the wild-type virus, but were similar to those of the revertant (Fig. 2a) . To confirm that the inocula contained the same amount of input virus, inocula were harvested after adsorption and assayed for virus titre. The inoculum titres are presented as virus yields on day 0 and showed that similar amounts of virus were used (Fig. 2a) . This was also confirmed by an indirect immunofluorescence assay (IFA) of the HF cells using anti-IE1 monoclonal antibody (mAb) 6E1 (Vancouver Biotech) (Fig. 2b) . To circumvent contamination problems, K175/180R and the revertant alleles were confirmed by directly sequencing viral DNAs obtained from cells infected with the virus stocks used in these experiments (data not shown). We also examined the accumulation of viral IE proteins IE1 and IE2, an early protein (p52, a DNA polymerase processivity factor) and a late protein (pp65, a tegument protein) in virus-infected cells. HF cells were infected with recombinant virus encoding wild-type or the K175/180R mutant or the revertant at an m.o.i. of 0?5. Total cell extracts were prepared at 48, 96 and 144 h after infection and analysed by Western blotting using specific antibodies. The result showed that the accumulation of viral proteins in wild-type, mutant and the revertant virus-infected cells was comparable (Fig. 2c) . The sumoylated form of IE2 was not detectable in this experiment due to the low level of IE2. However, the lack of IE2 sumoylation by the mutant virus and its restoration by the revertant were confirmed by immunoblot analysis using cell extracts that were prepared 72 h after a high m.o.i. (5?0) (Fig. 2d) . Considering the slightly delayed growth of both the mutant virus and the revertant relative to the wild-type in our multistep growth curve analysis, we could not exclude the possibility that the viral genome may have been altered at another site during the construction of the initial mutant virus. However, our overall results indicated that sumoylation of IE2 was not essential for the progression of infection in cultured fibroblast cells.
We also examined the localization patterns of the mutant IE2 in HF cells at early and late times after infection. Eight hours after infection, as for wild-type IE2, the mutant IE2(K175/180R) was initially localized as a mixture of nuclear punctate and diffuse forms. At 48 h post-infection, both the wild-type and mutant proteins accumulated in the pre-replication foci and in the viral DNA replication compartments (RCs) (Fig. 3a, b) . This result suggested that sumoylation of IE2 is not required for initial POD targeting to generate immediate transcription domains or for its incorporation into virus RCs in virus-infected HF cells. It has been shown that the cellular SUMO signals, possibly in the form of sumoylated cellular proteins, accumulate in virus RCs at late times in HCMV-infected cells (Ahn et al., 1999) . This suggests that the sumoylated cellular proteins may participate in or affect virus RCs. The two cellular proteins p53 and proliferating cell nuclear antigen (PCNA), identified as being involved in cellular DNA replication or repair, have been shown to be sumoylated (Gostissa et al., 1999; Hoege et al., 2002; Rodriguez et al., 1999) . Interestingly, p53 has been shown to accumulate in virus RCs in both herpes simplex virus type-1 (HSV-1) and HCMVinfected cells, whereas PCNA has been detected in virus RCs in HSV-1-infected cells (Fortunato & Spector, 1998; Wilcock & Lane, 1991) . IE2 was found to interact physically with SUMO-1 in vitro and some IE2-interacting partners were observed to interact with SUMO-1 in yeast, suggesting that IE2 may be associated with several cellular proteins by binding to covalently conjugated SUMO moieties (Ahn et al., 1999) . We thus investigated whether the lack of IE2 sumoylation affected the accumulation of cellular sumoylated proteins (including p53 and PCNA) in virus RCs.
HF cells were mock-infected or infected with either the wild-type or the mutant IE2(K175/180R) virus. At 48 h post-infection, cells were fixed in methanol and subjected to a double-labelled IFA. Mouse mAb against p52 and rabbit polyclonal antibody (pAb) against the UL112-113 viral proteins were used to detect the virus RCs (Ahn et al., 1999) . Antibodies against SUMO-1 (FL-101), p53 (DO-1) and PCNA (PC10) cellular proteins were purchased from Santa Cruz Biotech. The results obtained showed that IFA signals for SUMO-1, p53 and PCNA were detected in virus RCs in wild-type and in IE2(K175/180R) mutant The accumulation of SUMO-1, p53 and PCNA in virus RCs. HF cells were mock-infected or infected as described in (b) and a double-labelled IFA was carried out at 48 h using three different sets of antibodies: anti-p52 mouse mAb and anti-SUMO-1 rabbit pAb (left); anti-UL112-113 rabbit pAb and anti-p53 mouse mAb (centre); or anti-UL112-113 rabbit pAb and anti-PCNA mouse mAb (right). Viral proteins were visualized using FITC-labelled secondary antibodies, whereas cellular proteins were visualized using rhodamine/RedX-coupled secondary antibodies. Note that the cytoplasmic signals detected by rabbit Abs at 48 h in virus-infected cells are due to the non-specific binding of rabbit Abs to virus-induced immunoglobulin Fc receptor-like proteins (Ahn et al., 1999; Fortunato & Spector, 1998) .
virus-infected cells. This suggested that the lack of IE2 sumoylation did not affect the accumulation of IE2 in virus RCs and that it did not interfere with the recruitment of other virus replication proteins (p52 and UL112-113) or sumoylated cellular proteins into the virus RCs.
In this study, we used BAC technology to isolate and analyse a recombinant HCMV encoding a sumoylation-deficient IE2 mutant. We found that the initial reconstitution of the mutant virus in cells transfected with a mutant BAC clone was slightly delayed compared with cells transfected with wild-type BAC. This is consistent with a previous study, which found that the transactivation activity of the K175/ 180R mutant IE2 on viral early promoters such as UL84 and UL112-113 was somewhat reduced in co-transfected cells (Hofmann et al., 2000) . However, when the reconstituted mutant virus was used, it grew in HF cells as efficiently as the wild-type and revertant viruses, suggesting that sumoylation of IE2 is not required for virus growth in HF cells. The absence of significant virus growth defects in the sumoylation-deficient mutant IE2 virus may be explained by the complementary role of virion proteins present in the tegument and matrix. Alternatively, cell signalling elicited upon virus entry may compensate for the modest loss of transactivation activity shown by the mutant IE2. Recently, a recombinant HCMV encoding a mutant IE2 with a deletion of aa 136-290 was reported to exhibit delayed virus growth and severe reductions in the steadystate levels of some viral late proteins such as pp65 (UL83) and pp28 (UL99) at a low m.o.i. (Sanchez et al., 2002) . The two sumoylation sites mutated in our study lie within this deleted region, suggesting that the defect shown by the D136-290 mutant virus may be related to a lack of IE2 sumoylation. However, our results with the K175/180R mutant virus indicated that the observed defect of the D136-290 mutant virus was not due to the absence of IE2 sumoylation. Although we did not observe the effect of the absence of IE2 sumoylation in HF cells infected with the mutant virus in tissue culture, the possibility that the sumoylation of IE2 affects viral gene expression and replication only under the certain conditions that enhance cellular sumoylation activity cannot be excluded.
